NanoGroup S.A.
NNG | WAR
Overview
Corporate Details
- ISIN(s):
- PLNNGRP00011 (+3 more)
- LEI:
- 259400HXWEAZUWRLY648
- Country:
- Poland
- Address:
- Warszawa Rakowiecka 36, 02-532 Warszawa
- Website:
- https://en.nanogroup.eu/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Mission of NanoGroup is to build a cluster of medical and biotechnological companies active in the field of diagnostics, therapy and rehabilitation of oncological patients. Currently, the group is managing five technologically advanced nanoengineering projects organized under three specialized startups. NanoGroup plans to sell licenses to its early-stage solutions (pre-clinical and clinical phase 1st) to international biotech companies and pharmaceutical companies.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for NanoGroup S.A..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-12 22:27 |
Director's Dealing
Powiadomienie
|
Polish | 4.3 KB | |
| 2025-08-12 22:27 |
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
|
Polish | 472 bytes | |
| 2025-08-12 22:20 |
Director's Dealing
Powiadomienie
|
Polish | 4.3 KB | |
| 2025-08-12 22:20 |
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
|
Polish | 466 bytes | |
| 2025-08-12 22:12 |
Director's Dealing
Powiadomienie
|
Polish | 4.3 KB | |
| 2025-08-12 22:12 |
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
|
Polish | 461 bytes | |
| 2025-08-12 22:04 |
Director's Dealing
Powiadomienie
|
Polish | 4.3 KB | |
| 2025-08-12 22:04 |
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
|
Polish | 482 bytes | |
| 2025-08-12 16:19 |
Share Issue/Capital Change
Zakończenie subskrypcji akcji zwykłych na okaziciela serii K - Content (PL)
|
Polish | 3.7 KB | |
| 2025-08-11 16:14 |
Delisting Announcement
Oświadczenie KDPW
|
Polish | 175.4 KB | |
| 2025-08-11 16:14 |
Share Issue/Capital Change
Asymilacja akcji oznaczonych kodem "PLNNGRP00086" z notowanymi akcjami oznaczon…
|
Polish | 669 bytes | |
| 2025-08-06 18:01 |
Share Issue/Capital Change
Dopuszczenie i wprowadzenie do obrotu giełdowego Akcji Serii L1, M1, M2, M3, M4…
|
Polish | 2.0 KB | |
| 2025-08-04 14:39 |
Regulatory News Service
Zawarcie przez spółkę zależną od NanoGroup S.A. umowy o dofinansowanie projektu…
|
Polish | 6.2 KB | |
| 2025-07-22 18:59 |
Transaction in Own Shares
Zawarcie transakcji sprzedaży akcji własnych spółki - Content (PL)
|
Polish | 1.2 KB | |
| 2025-07-10 13:26 |
Share Issue/Capital Change
Uchwała
|
Polish | 67.2 KB |
Automate Your Workflow. Get a real-time feed of all NanoGroup S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for NanoGroup S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Theradiag | France | ALTER | |
|
Theranexus | France | ALTHX | |
|
Thor Medical ASA | Norway | NANOV | |
|
TME Pharma N.V. | Germany | ALTME | |
|
Toleranzia AB | Sweden | TOL | |
|
Transgene | France | TNG | |
|
Tvardi Therapeutics Inc. | United States of America | TVRD | |
|
Ulisse Biomed | Italy | UBM | |
| Uni-Bio Science Group Ltd | Hong Kong | N/A | ||
|
Univo Pharmaceuticals Ltd. | Israel | UNVO-M |